Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15114097 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Simultaneous Pancreas-kidney Transplantation With Campath Protocol
Condition: Pancreas-Kidney Transplantation
Interventions: Drug: Alemtuzumab;   Drug: Rabbit Anti-Human Thymocyte Globulin

Indicates status has not been verified in more than two years